Waste Management (WM) — Q2 2026 Earnings Preview

Ticker: WM Earnings Date: July 28, 2026 (after market close); Conference Call July 29, 2026 at 10:00 a.m. ET Prepared: July 28, 2026

Earnings Preview

Key Takeaway: The setup into Q2 2026 is modestly constructive — consensus sits at a manageable bar with the wildfire comp headwind well-telegraphed — but the single biggest swing factor is whether operating EBITDA margin can hold near 30% despite the ~$85M revenue drag from lapping prior-year wildfire volumes.

Heading into Q2 2026, WM faces a well-understood but real headwind: approximately $85 million in wildfire-related revenue that benefited Q2 2025 will not repeat, creating a tough year-over-year margin comparison that management explicitly flagged on the Q1 call. Consensus has absorbed this, with the EBITDA estimate of ~$2.03B implying roughly 30.3% margin — a modest step-up from Q1's 29.8% adjusted margin but below the 30.6% posted in Q3 2025. Management's tone at the June 3 William Blair conference was constructive: the CFO reiterated the "year of harvest" framing, confirmed 80% of RNG volume is locked in for 2026, and described Healthcare Solutions as tracking ahead of internal plan with cross-sell already generating ~$28M of EBITDA. Estimate revisions have been essentially flat since the Q1 print — the Q2 EPS consensus of ~$1.98 is nearly unchanged from the post-Q1 baseline of ~$1.98, suggesting the Street is neither chasing upside nor cutting numbers. The stock has outperformed the S&P 500 since the Q1 print (+4.6% vs. +3.9%) but lagged XLI (+7.2%), trading at ~13.9x NTM EV/EBITDA — a slight compression from 14.7x a year ago, consistent with the market pricing in a more normalized growth profile. The key wildcard is volume trajectory: management guided to low-single-digit industrial growth and improving commercial trends, and peer WCN's Q2 beat (revenue +6.4%, EBITDA margin 32.8%) with raised full-year guidance is a positive read-through for the broader waste sector heading into the print.

KPIs & Consensus Expectations

Key Takeaway: Consensus sets a manageable bar on EBITDA and EPS, with the wildfire comp headwind already embedded in estimates. Operating EBITDA margin is the bigger swing factor — any upside from pricing or Healthcare Solutions cost discipline could drive a beat, while volume softness or commodity weakness could pressure the print.

Table 1 — Current Quarter Snapshot (Q2 2026)

KPI

Last Quarter Actual (Q1 2026)

Prior Year Period (Q2 2025 Actual)

Q2 2026 Consensus Estimate

YoY Change (Est. vs. Actual)

Guidance (FY 2026)

Consensus vs. Guidance

Revenue

$6,227M

$6,430M

$6,707M

+4.3%

FY ~$26.5B (implied)

On track

Operating EBITDA

$1,853M (adj.)

$1,923M

$2,032M

+5.7%

$8.15–$8.25B

~$8.20B cons. vs. $8.20B mid ≈ 0%

Operating EBITDA Margin

29.8% (adj.)

29.9%

~30.3%

+40 bps

~30.9% FY implied

Slight discount to FY run-rate

Adj. EPS (Diluted – Operating)

$1.81

$1.92

$1.98

+3.1%

FY ~$8.17 cons.

On track

Core Price (Collection & Disposal)

6.3%

6.4%

~6.1%

-30 bps

~5.9% FY

Slightly above FY pace

Volume Growth (Collection & Disposal)

-1.5% (weather/wildfire comp)

+2.1%

~-0.1%

N/M (wildfire comp)

~+0.6% FY

Below FY pace; wildfire drag

Free Cash Flow (Company-Defined)

$920M

$818M

~$1,072M

+31.1%

$3,750–$3,850M

~$3,868M cons. vs. $3,800M mid ≈ +1.8%

Sources: Visible Alpha consensus and actuals data. All consensus figures as of July 28, 2026.

Table 2 — Beat/Miss History (Last 8 Quarters)

Top 2 KPIs: Operating EBITDA and Adjusted EPS (Diluted – Operating)

Quarter

KPI

Reported

Consensus

Surprise %

Result

Q1 2026

Op. EBITDA

$1,853M

$1,872M

-1.0%

Miss

Q1 2026

Adj. EPS

$1.81

$1.61

+12.4%

Beat

Q4 2025

Op. EBITDA

$1,974M

$1,934M

+2.1%

Beat

Q4 2025

Adj. EPS

$1.93

$1.94

-0.5%

In-line

Q3 2025

Op. EBITDA

$1,970M

$1,970M

0.0%

In-line

Q3 2025

Adj. EPS

$1.98

$2.03

-2.5%

Miss

Q2 2025

Op. EBITDA

$1,923M

$1,880M

+2.3%

Beat

Q2 2025

Adj. EPS

$1.92

$1.89

+1.6%

Beat

Q1 2025

Op. EBITDA

$1,750M

$1,718M

+1.9%

Beat

Q1 2025

Adj. EPS

$1.67

$1.60

+4.4%

Beat

Q4 2024

Op. EBITDA

$1,706M

$1,703M

+0.2%

In-line

Q4 2024

Adj. EPS

$1.70

$1.79

-5.0%

Miss

Q3 2024

Op. EBITDA

$1,711M

$1,686M

+1.5%

Beat

Q3 2024

Adj. EPS

$1.96

$1.91

+2.6%

Beat

Q2 2024

Op. EBITDA

$1,923M

$1,880M

+2.3%

Beat

Q2 2024

Adj. EPS

$1.92

$1.89

+1.6%

Beat

Pattern: WM has beaten or met Operating EBITDA consensus in 7 of the last 8 quarters, with the lone Q1 2026 EBITDA miss driven by weather and wildfire comp headwinds; Adj. EPS has beaten in 6 of 8 quarters, with the Q1 2026 EPS beat (+12.4%) driven by a lower-than-expected tax rate from RNG production tax credits. Source: Visible Alpha consensus and actuals data.

Guidance & Commentary Evolution

Key Takeaway: WM reaffirmed full-year guidance at Q1 earnings (April 28) and management's tone at the June 3 William Blair conference was incrementally positive on Healthcare Solutions and RNG, with no formal guidance revision. The bar is unchanged but confidence in achieving it has risen.

Metric

Initial Guidance (Q1 2026 Earnings Call, Apr 28)

Revised Guidance

Current Consensus

Note

FY 2026 Revenue

Reaffirmed full-year guidance; ~$26.5B implied

~$26.5B

No post-earnings revision; management confident in achieving full-year revenue guidance

FY 2026 Operating EBITDA

$8.15–$8.25B

~$8.20B

Reaffirmed at Q1; consensus at midpoint

FY 2026 Free Cash Flow

$3,750–$3,850M

~$3,868M

Consensus slightly above guidance midpoint; FCF inflection driven by sustainability CapEx step-down

Sustainability EBITDA Contribution

$240–$250M growth in 2026

N/A (not separately tracked in VA)

80% of RNG volume locked in for 2026 (up from 60% at guidance); 3 more RNG plants expected online in Q2

Healthcare Solutions Revenue Growth

~3% for FY 2026 (bridge year); mid-single-digit exit rate H2 2026

N/A (not separately tracked in VA)

At June 3 conference, CFO confirmed tracking ahead of plan; cross-sell generating ~$28M EBITDA; synergy target potentially $325M vs. $300M goal

Share Repurchases

$2B for FY 2026; 55–60% in H2

N/A

On track; $344M repurchased in Q1; leverage returned to 2.5–3.0x target range

Q2 2026 Margin Outlook

Tough comp vs. Q2 2025 wildfire volumes (~$85M revenue, strong EBITDA flow-through); margin improvement expected in H2

~30.3% EBITDA margin

Management flagged Q2 as the toughest comp quarter; expects H2 margin trajectory similar to 2025 seasonality

Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have been remarkably stable since the Q1 print — Q2 EPS consensus is essentially flat and FY EBITDA consensus is within 0.1% of the post-Q1 baseline — suggesting the Street has fully absorbed the wildfire comp headwind and is not pricing in incremental risk or upside. The gap between consensus and guidance midpoint is negligible, leaving the print as a clean execution test.

KPI (Period)

Estimate ~5 Days Post Q1 Earnings (May 5, 2026)

Current Consensus (Jul 28, 2026)

Estimate Δ (%)

Initial Guidance (Q1 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance (%)

Revenue (Q2 2026)

$6,685M

$6,707M

+0.3%

No Q2-specific guidance

N/A

Operating EBITDA (Q2 2026)

$2,030M

$2,032M

+0.1%

No Q2-specific guidance

N/A

Adj. EPS (Q2 2026)

$1.98

$1.98

0.0%

No Q2-specific guidance

N/A

Revenue (FY 2026)

$26,508M

$26,544M

+0.1%

Reaffirmed FY guidance

Unchanged

On track

Operating EBITDA (FY 2026)

$8,196M

$8,202M

+0.1%

$8,150–$8,250M

Unchanged

~0% vs. $8,200M mid

Adj. EPS (FY 2026)

$8.16

$8.17

+0.1%

No formal EPS guidance

N/A

Free Cash Flow (FY 2026)

$3,820M

$3,868M

+1.3%

$3,750–$3,850M

Unchanged

+1.8% vs. $3,800M mid

Estimates have been essentially flat since the Q1 print, with Q2 and FY revisions of less than 0.3% across all key metrics. This stability reflects the Street's confidence in WM's guidance framework and suggests the wildfire comp headwind is fully priced in. Source: Visible Alpha consensus and actuals data.

Stock Performance

Key Takeaway: WM has outperformed the S&P 500 since the Q1 print (+4.6% vs. +3.9%) but lagged the XLI industrials ETF (+7.2%), consistent with WM's defensive/utility-like characteristics underperforming in a risk-on industrial rally. The 1-month re-rating (+6.7% price, +4.9% EV/EBITDA multiple expansion) suggests recent momentum is multiple-driven rather than estimate-driven, which could be fragile if Q2 disappoints.

Chart: WM vs. XLI vs. S&P 500 — Indexed Performance Since Q1 2026 Earnings (April 28, 2026)

WM vs. XLI vs. S&P 500 — Indexed to 100 at April 28, 2026 (Q1 2026 Earnings Date). WM: dark navy; XLI (Industrials ETF): mid-grey dashed; S&P 500: light grey dashed. Source: Yahoo Finance.

Performance Summary (April 28 – July 28, 2026): WM +4.6% ($227.35 → $237.90) | XLI +7.2% ($170.98 → $183.20) | SPY +3.9% ($711.69 → $739.09). WM's 1-month performance of +6.7% was primarily multiple-driven (EV/EBITDA expanded ~+4.9% over 1 month), while the 3-month and 6-month windows show modest multiple compression, suggesting the longer-term driver has been estimate stability rather than re-rating. The stock trades at 13.9x NTM EV/EBITDA vs. 14.7x a year ago, reflecting normalization from peak sustainability-investment premium. Source: Yahoo Finance; Visible Alpha stock performance decomposition data.

Material News & Developments

Key Takeaway: The most important development since Q1 earnings is the June 3 William Blair conference, where management provided incrementally positive color on Healthcare Solutions integration progress and RNG volume lock-in — both of which reduce downside risk heading into the Q2 print.

Peer Commentary: Current-Quarter Read-Throughs (Q2 2026)

Key Takeaway: Peer commentary from the last 60 days is broadly constructive for WM's Q2 print. Waste Connections' Q2 beat (revenue +6.4%, EBITDA margin 32.8% with 70 bps underlying expansion) is the most direct positive read-through, confirming solid pricing power and margin resilience despite fuel cost headwinds. Casella Waste and Clean Harbors conference commentary from June confirmed normal seasonal volume recovery and improving industrial demand — both supportive for WM's volume trajectory.

Note: Only commentary about Q2 2026 (current reporting quarter) or forward-looking statements made after peers' last earnings are included below. Retrospective Q1 2025 or Q1 2026 results-only discussion is excluded.

Waste Connections (WCN) — Q2 2026 Earnings (July 22–23, 2026)

Relevance: WCN is WM's closest direct peer in solid waste collection, transfer, and disposal. WCN reports on a calendar quarter basis (Q2 ended June 30), making its results a direct read-through for WM's Q2 2026 print.

Casella Waste Systems (CWST) — June 2026 Conference Commentary

Relevance: Casella is a Northeast-focused solid waste operator. Conference commentary from June 2–10, 2026 provides current-quarter color on pricing, volumes, and macro conditions relevant to WM's Q2 2026 setup.

Clean Harbors (CLH) — June 2026 Conference Commentary

Relevance: Clean Harbors is a hazardous waste and environmental services company. While not a direct solid waste peer, CLH's commentary on industrial demand, special waste, and macro conditions provides useful read-through for WM's industrial and special waste volumes.

Peer Read-Through Summary Table

Peer

Source / Date

Key Signal for WM Q2

Direction

WCN

Q2 2026 Earnings (Jul 22–23)

Revenue +6.4%, EBITDA margin 32.8% (+70 bps underlying), raised FY guidance; core price 5.6%; July volume trends improving

Positive

CWST

William Blair Conference (Jun 2); Stifel Summit (Jun 10)

Normal seasonal volume recovery entering Q2; pricing 4–5%; fuel surcharges successfully implemented; volumes in line with budget

Modestly Positive

CLH

Wells Fargo Conference (Jun 9); Stifel Summit (Jun 10)

ISM expansion for 4–5 consecutive months; PFAS volumes exceeding expectations; industrial demand 'green shoots'; pricing discipline intact

Modestly Positive

Insider Transaction Activity

Key Takeaway: Insider activity since the Q1 earnings print is minimal — only one open-market sale was disclosed, by the SVP of Enterprise Strategy, which is not a top-tier executive signal. There are no open-market buys and no unusual clustering of sales. The absence of significant insider selling ahead of the print is a mild positive signal.

Name

Title

Transaction Type

Shares / Value

Execution Date

Disclosure Date

Note

Rafael Carrasco

SVP of Enterprise Strategy

Open Market Sale

2,655 shares (est. ~$585K at ~$220/share)

June 5, 2026

June 8, 2026

Discretionary sale; not under a disclosed 10b5-1 plan. SVP-level, not C-suite; not a strong directional signal.

Source: SEC Form 4 filings database. Window: April 28, 2026 – July 28, 2026 (since Q1 2026 earnings). Only open-market buys (code P) and open-market sales (code S) are included. No Form 144 filings or 10b5-1 plan initiations were identified for WM in this window. The absence of C-suite selling and the lack of any open-market buying are both consistent with a neutral-to-slightly-positive insider signal heading into the Q2 print.